Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Faner Canet (Barcelona, Spain). Transcriptomic and epigenetic changes in the lung of patients with severe COPD. 374

Member's Comments

No comment yet.

Related content which might interest you: Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma Source: Eur Respir J, 50 (3) 1602298; 10.1183/13993003.02298-2016 Year: 2017 Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations. Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Analysis and comparison of the transcriptome of COPD patients with and without lung cancer Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Cellular and structural changes in peripheral airways of subjects with severe COPD Source: Eur Respir J 2001; 18: Suppl. 33, 91s Year: 2001 Metabolic changes in lung ageing and COPD Source: International Congress 2019 – Metabolic alterations in lung ageing and disease Year: 2019 Transcriptome profiling of platelets from patients with severe asthma. Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Comparison between COPD and non-COPD patients with established cardiovascular diseases: A profiling of respiratory symptoms and functional status Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Microarray gene expression profiles in lung tissue of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 537s Year: 2007 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Longitudinal profiling of viral infections in COPD patients and their implication to exacerbations Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Multi-omic molecular profiling of lung cancer in COPD Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017 Year: 2018 Mechanisms underlying pulmonary vascular changes in COPD patients Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008